83/100BSherwin-Williams Company (The) stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Sherwin-Williams Company (The) is 377.85, 7.1% above the current price of 352.90. Their targets range from 329.00 to 420.00.
Of the 13 firms that rated Sherwin-Williams Company (The) in the past 12 months, 9 rate it buy or strong buy, 4 hold and 0 sell or strong sell (each firm at its latest rating): a Buy consensus.
Analysts' 1-year price targets range from 329.00 to 420.00, with an average of 377.85.
| Buy | 9 | |
| Hold | 4 | |
| Sell | 0 |
12-month price target
| Highest target | 420.00 |
| Average target | 377.85 |
| Lowest target | 329.00 |
| Current price | 352.90 |
Sherwin-Williams Company (The) price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Sherwin-Williams Company (The) price target and rating?
How analysts rate Sherwin-Williams Company (The), month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
9 of 13 firms rate it buy now, against 10 of 13 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Sherwin-Williams Company (The) analyst upgrades, downgrades and price targets
The latest rating change came on 2 June 2026, when UBS downgraded Sherwin-Williams Company (The) from Buy to Neutral. Its price target is 330.00, from 420.00. The most recent new target came from D.A. Davidson on 28 October 2026: 390.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 28 Oct 2026 | D.A. Davidson Garik Shmois | — | 400.00 → 390.00 | -2.5% | 320.29 |
| 28 Oct 2026 | UBS | Reiterated · Neutral | 363.00 → 370.00 | +1.9% | 321.28 |
| 28 Oct 2026 | Barclays | Reiterated · Equal Weight | 348.00 → 329.00 | -5.5% | 326.01 |
| 28 Oct 2026 | Guggenheim | Reiterated · Buy | 400.00 → 375.00 | -6.3% | 326.01 |
| 27 Oct 2026 | Jefferies Laurence Alexander | — | 375.00 → 353.00 | -5.9% | 335.16 |
| 12 Oct 2026 | Barclays | — | 348.00 | — | 320.21 |
| 9 Oct 2026 | RBC Capital Arun Viswanathan | Reiterated · Outperform | 390.00 → 392.00 | +0.5% | 318.54 |
| 6 Oct 2026 | Melius Research Michael Rehaut | — | 367.00 | — | 318.46 |
| 5 Oct 2026 | UBS | Reiterated · Neutral | 390.00 → 363.00 | -6.9% | 319.51 |
| 25 Sept 2026 | Wells Fargo | Reiterated · Equal Weight | 360.00 → 340.00 | -5.6% | 320.40 |
| 24 Sept 2026 | Mizuho Securities John Roberts | — | 410.00 → 396.00 | -3.4% | 326.46 |
| 24 Aug 2026 | D.A. Davidson | — | 400.00 | — | 346.73 |
| 3 Aug 2026 | Guggenheim | — | 400.00 | — | 340.85 |
| 29 Jul 2026 | Goldman Sachs Duffy Fischer | — | 420.00 | — | 343.88 |
| 29 Jul 2026 | BMO Capital | Reiterated · Outperform | 355.00 → 405.00 | +14.1% | 341.42 |
| 29 Jul 2026 | UBS Joshua Spector | — | 330.00 → 390.00 | +18.2% | 341.57 |
| 29 Jul 2026 | Wells Fargo | Reiterated · Equal Weight | 365.00 → 360.00 | -1.4% | 354.27 |
| 29 Jul 2026 | Morgan Stanley Vicent Andrews | Reiterated · Overweight | 395.00 | — | 354.27 |
| 28 Jul 2026 | Jefferies Laurence Alexander | — | 375.00 | — | 354.27 |
| 8 Jun 2026 | Berenberg Bank Aron Ceccarelli | — | 380.00 | — | 305.30 |
| 3 Jun 2026 | BMO Capital | — | 355.00 | — | 297.49 |
| 2 Jun 2026 | UBS | Downgraded · Buy → Neutral | 420.00 → 330.00 | -21.4% | 294.86 |
| 29 Apr 2026 | Evercore ISI | Reiterated · Outperform | 390.00 | — | 317.61 |
| 10 Apr 2026 | Wells Fargo | Downgraded · Overweight → Equal Weight | 410.00 → 365.00 | -11.0% | 335.59 |
| 17 Feb 2026 | Mizuho Securities | Reiterated · Outperform | 390.00 → 410.00 | +5.1% | 368.89 |
| 30 Jan 2026 | UBS | — | 415.00 → 420.00 | +1.2% | 355.36 |
| 30 Jan 2026 | RBC Capital | Reiterated · Outperform | 405.00 → 390.00 | -3.7% | 354.58 |
| 22 Jan 2026 | Deutsche Bank | — | 380.00 | — | 350.63 |
| 12 Jan 2026 | UBS Joshua Spector | Reiterated · Buy | 422.00 → 415.00 | -1.7% | 356.34 |
| 7 Jan 2026 | Vertical Research | — | 371.00 | — | 340.09 |
| 18 Dec 2025 | Mizuho Securities | Reiterated · Outperform | 400.00 → 390.00 | -2.5% | 327.95 |
| 18 Dec 2025 | Citigroup | Upgraded · Neutral → Buy | — | — | — |
Sherwin-Williams Company (The) EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Sherwin-Williams Company (The)'s EPS to grow 12.6% a year until 2028. Over the last 5 years it grew 6.9% a year, and over the last 3 years 10.0%.
Analysts expect Sherwin-Williams Company (The)'s revenue to grow 5.1% a year until 2028. Over the last 5 years it grew 5.1% a year, and over the last 3 years 2.1%.
Revenue
EPS
Does Sherwin-Williams Company (The) beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 3.9% off the result, either way, and their revenue estimate 1.3%, over the last 12 quarters.
- EPS beats
- 70 / 136
- Revenue beats
- 77 / 120
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +0.9%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 27 Oct 2026 | 3.69 | 3.63 | -1.6% | 6.78B | 6.86B | +1.2% |
| Q2 FY2026 | 28 Jul 2026 | 3.52 | 3.70 | +5.1% | 6.60B | 6.79B | +2.8% |
| Q1 FY2026 | 28 Apr 2026 | 2.27 | 2.35 | +3.5% | 5.56B | 5.67B | +1.9% |
| Q4 FY2025 | 29 Jan 2026 | 2.16 | 2.23 | +3.2% | 5.57B | 5.60B | +0.5% |
| Q3 FY2025 | 28 Oct 2025 | 3.45 | 3.59 | +4.1% | 6.20B | 6.36B | +2.5% |
| Q2 FY2025 | 22 Jul 2025 | 3.76 | 3.38 | -10.1% | 6.29B | 6.31B | +0.3% |
| Q1 FY2025 | 29 Apr 2025 | 2.15 | 2.25 | +4.7% | 5.40B | 5.31B | -1.7% |
| Q4 FY2024 | 30 Jan 2025 | 2.06 | 2.09 | +1.5% | 5.32B | 5.30B | -0.4% |
| Q3 FY2024 | 22 Oct 2024 | 3.54 | 3.37 | -4.8% | 6.20B | 6.16B | -0.6% |
| Q2 FY2024 | 23 Jul 2024 | 3.48 | 3.70 | +6.3% | 6.33B | 6.27B | -0.9% |
| Q1 FY2024 | 23 Apr 2024 | 2.21 | 2.17 | -1.8% | 5.50B | 5.37B | -2.4% |
| Q4 FY2023 | 25 Jan 2024 | 1.80 | 1.81 | +0.6% | 5.22B | 5.25B | +0.6% |
Sherwin-Williams Company (The) stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Sherwin-Williams Company (The)'s earnings keep growing at the 8.6% a year analysts expect to FY2028, it would earn about 17.33 a share in FY2030. At the P/E it has traded at over the last five years (30.3 to 49.6) that is 525.18 to 859.41 a share, or 601.97 at its average P/E of 34.7. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 12.04 | 364.83 | 418.18 | 597.01 |
| FY2027 | 13.20 | 399.98 | 458.46 | 654.52 |
| FY2028 | 14.68 | 444.98 | 510.05 | 728.17 |
| FY2029 (extrapolated) | 15.95 | 483.42 | 554.11 | 791.07 |
| FY2030 (extrapolated) | 17.33 | 525.18 | 601.97 | 859.41 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 8.6% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (30.3, 34.7, 49.6).
Is Sherwin-Williams Company (The) stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Sherwin-Williams Company (The)'s P/E of 32.1 is around the middle of its 5-year range (25.8 to 45.6, median 32.6). It is in line with its own history. Buyers pay less for each point of growth than usual: a PEG of 2.5 on expected growth against 4.7 on its median P/E and past five years' growth. At its usual P/E (32.6 × EPS of 10.98), Sherwin-Williams Company (The)'s fair value is 357.67, close to the price of 352.90. Its forward P/E, on the consensus for FY2026, is 29.3.
Fair value is the usual (median) P/E of the last five years times the earnings per share of the last twelve months; the ends of the bar are the same earnings at its lowest and highest P/E of those years (25.8 and 45.6). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 32.14
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 32.57
- Five-year P/E range
- 25.8 – 45.6
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 29.32
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 3.72
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +7.1%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.